Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer PatientsGerardo Botti, Maurizio Di Bonito|International Journal of Molecular Sciences|2017Cited by 112